Deep Tech Startups

Desentum is a clinical-stage biopharmaceutical company developing allergen immunotherapy products that reprogram immune responses to allergens toward tolerance. The company targets both respiratory and food allergies, with its lead asset currently in phase II clinical trials.

1 investor

Detail Earth provides high-resolution aerial imagery, down to 5 cm resolution with vertical and oblique views updated three times a year, accessible on any device. It includes AI-based measurement tools, 3D visualization, map editing, and an AI copilot for turning imagery into insights.

1 investor

D&I Solutions develops technology to detect and interdict unauthorized wireless communications, targeting contraband cell phone use by inmates in correctional facilities. The system focuses on identifying and blocking unauthorized cellular calls made from within prisons.

1 investor

Detraxi is a privately held company developing emerging technology, seeking development funding and licensing partnerships. The page provides limited detail about the specific product or industry.

1 investor

Deutelio develops fusion energy technology, centered on its proprietary Polomac plasma confinement approach intended to improve efficiency in fusion reactors. The company positions its research as a route toward commercial fusion power and Net Zero emissions goals.

1 investor

Deuterium Energetics develops energy technology solutions, though specific product details are not provided on the team page.

1 investor

DEVAR develops AI-powered augmented reality technology, including a platform that generates AR experiences, 3D models, and interactive content from text descriptions, and a Large Geospatial Model for spatial mapping and persistent AR content placement. It serves creators, brands, and enterprises across sectors such as retail, education, manufacturing, marketing, arts, and architecture.

1 investor

DevCo is an investment and venture capital firm that provides portfolio companies with hands-on operational resources, customized ownership structures, and capital to support growth.

1 investor

Dexlabs is an engineering design and manufacturing services firm offering product design, 3D modeling, rapid prototyping via 3D printing, additive manufacturing, and injection molding design. It works with startups and large enterprises across industries such as consumer electronics to take ideas from concept to full-scale production.

1 investor

DGG builds RapidPipeline, software for automating 3D content pipelines that lets companies process and optimize 3D models as easily as 2D images. It serves studios, brands, retailers, and platform companies for digital production and marketing workflows.

1 investor

Dharmacon Reagents provides synthetic oligonucleotides, gene modulation, and gene editing solutions for functional genomics research, enabling researchers to study genetic networks and advance therapeutic discovery. The company offers a comprehensive range of tools for DNA, RNA, and protein-level research, including RNAi, CRISPR gene editing, and screening libraries for academic and commercial researchers.

1 investor

Diamante develops plant-based compounds for therapeutic and diagnostic systems targeting autoimmune diseases. The company applies molecular farming techniques to produce biopharmaceuticals and aims to advance treatments from research to clinical applications.

1 investor

Diamidex develops microbiological analysis solutions for water safety, including equipment, software, and reagents designed to detect and count targeted microorganisms with improved speed and accuracy for laboratory use.

1 investor

Diamond Microwave manufactures high-performance GaN solid-state microwave power amplifiers for radar, communications, and directed energy applications across terrestrial, airborne, and space systems. It offers broadband, medium-power, high-power, and custom amplifier solutions optimized for size, weight, and power constraints.

1 investor

DIAS Infrared manufactures pyrometers, thermal imaging cameras, and software solutions for non-contact temperature measurement in industrial production and quality assurance processes. The company serves manufacturing and automation industries with tools for thermal inspection, weld monitoring, and automated temperature data capture.

1 investor

Diffract Technology is developing holographic sensor technology for true 3D optical precision sensing. The company is in stealth mode with proof-of-concept and prototypes under active development.

1 investor

Diffractive.ai is developing an autonomous AI system for materials science that learns from real-world experiments to accelerate scientific discovery.

1 investor

Digerati Technologies is a publicly traded holding company operating subsidiaries in data centers, telecommunications, green compute, and energy infrastructure. The company acquires and operates mission-critical digital infrastructure assets globally with a focus on sustainability and long-term shareholder value.

1 investor

Digi.Bio develops a single-cell, AI-driven, lab-on-a-chip platform that profiles the fate and performance of individual cells to evaluate how therapies perform over time. The technology, aimed at drug developers working on cell-based and immune therapies, measures cytotoxicity, cell motility, and cell-cell interactions to compare drug efficacy.

1 investor

DigiChem operates an AI-native platform for on-demand custom molecule synthesis, letting users design and order molecules online and access process and analytical data. It serves innovators needing specialty chemicals from lab scale to production, with manufacturing in the USA.

1 investor

Digitais provides AI-powered solutions and custom implementations for enterprise clients seeking process automation and analytics. The company specializes in bespoke AI applications designed to improve operational efficiency and sustainability.

1 investor

Digital Anatomics develops AI-powered surgical planning software that generates personalized patient-specific guides for surgeons in complex procedures. The platform serves hospitals, surgical teams, and healthcare providers across Spain to improve surgical precision and patient outcomes.

1 investor

Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.

1 investor

DSSP develops and manufactures specialized propellant chemicals for aerospace and energy applications, including green monopropellants and ionic liquid oxidizers.

1 investor